Marty Makary resigns as FDA commissioner after internal tensions

Politics Marty Makary resigns as FDA commissioner after internal tensions By Olivia Rinaldi, Olivia Rinaldi White House reporter Olivia Rinaldi is a White House reporter at CBS News. She covered President Trump's 2024 presidential campaign and was previously an associate producer for "CBS Evening News with Norah O'Donnell" and a broadcast associate for "Face the Nation." She is based in Washington, D.C. Read Full Bio Olivia Rinaldi, Margaret Brennan, Margaret Brennan Moderator, "Face the Nation with Margaret Brennan;" Chief foreign affairs correspondent Margaret Brennan is moderator of "Face the Nation with Margaret Brennan" on CBS. Based in Washington, D.C., Brennan is also the Network's chief foreign affairs correspondent and a contributing correspondent to 60 Minutes. Additionally, she appears regularly on the "CBS Evening News," leading coverage from Washington when news breaks on the political and foreign affairs fronts. Read Full Bio Margaret Brennan, Kathryn Watson Kathryn Watson Politics Reporter Kathryn Watson is a politics reporter for CBS News Digital, based in Washington, D.C. Read Full Bio Kathryn Watson May 12, 2026 / 2:00 PM EDT / CBS News Add CBS News on Google Washington — Marty Makary resigned as commissioner of the Food and Drug Administration on Tuesday, according to two sources familiar with the matter, stepping aside amid a swirl of reports that his tenure was coming to an end over internal policy disagreements.His departure follows reports of conflict and tension over the FDA's agenda. On May 6, the FDA approved some flavored e-cigarettes from the vaping company Glas Inc., and touted its safety restrictions to limit use by young people. According to The Wall Street Journal, the move came only after Mr. Trump pressured Makary to approve the fruit-flavored vapes, which he had been refusing to do. One of the sources said Makary is leaving over the e-cigarette dispute, adding that Makary didn't want to approve the flavored varieties but...